Detalles de la búsqueda
1.
Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry.
Br J Dermatol
; 190(3): 355-363, 2024 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37846976
2.
Cardiovascular Screening Practices and Statin Prescription Habits in Patients with Psoriasis among Dermatologists, Rheumatologists and Primary Care Physicians.
Acta Derm Venereol
; 103: adv5087, 2023 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36987537
3.
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results.
Clin Exp Dermatol
; 48(9): 991-997, 2023 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37098171
4.
Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group.
J Eur Acad Dermatol Venereol
; 37(12): 2517-2525, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37625815
5.
Ustekinumab to guselkumab transitions: A series of 54 patients emulating the navigate trial in real life.
Dermatol Ther
; 35(10): e15757, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36190008
6.
Effectiveness and safety of guselkumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group.
Dermatol Ther
; 35(2): e15231, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34820971
7.
Fast and sustained improvement of patient-reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting.
Dermatol Ther
; 35(8): e15653, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35731640
8.
Secukinumab is effective and safe in the long-term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients.
Dermatol Ther
; 35(12): e15929, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36223184
9.
Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry.
J Am Acad Dermatol
; 83(1): 139-150, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32213306
10.
A retrospective, observational multicenter study of 141 patients treated with ustekinumab 90 mg.
Dermatol Ther
; 33(4): e13678, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32447810
11.
The effectiveness and safety of ixekizumab in psoriasis patients under clinical practice conditions: A Spanish multicentre retrospective study.
Dermatol Ther
; 33(6): e14066, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32713119
12.
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis.
Ann Rheum Dis
; 78(3)2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30552173
13.
Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain.
Rheumatol Int
; 38(6): 1115-1124, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29417210
14.
Infantile hemangioma with minimal or arrested growth as the skin manifestation of PHACE syndrome.
Pediatr Dermatol
; 35(5): 622-627, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29984853
15.
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis.
J Am Acad Dermatol
; 84(2): 513-517, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33122022
16.
A deletion at ADAMTS9-MAGI1 locus is associated with psoriatic arthritis risk.
Ann Rheum Dis
; 74(10): 1875-81, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25990289
17.
Experience in patients with hidradenitis suppurativa and COVID-19 symptoms.
J Am Acad Dermatol
; 83(4): e309-e311, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32603717
18.
The risk of urinary tract infections in patients with psoriasis on systemic medications in Biobadaderm Registry: A prospective cohort study.
J Am Acad Dermatol
; 82(3): 738-741, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31306726
19.
Assessment of cardiovascular risk in patients with moderate to severe plaque psoriasis.
J Drugs Dermatol
; 13(10): 1240-7, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25607559
20.
Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting.
Int J Dermatol
; 63(4): 503-511, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38168847